FindTrial
Sign In

Amount of medicines wasted during cancer treatment

Assessment of Wastage and Economic Loss of Anti-cancer drugs in Oncology services in NEIGRIHMS, India: A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/10/016173
Enrollment
200
Registered
2018-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: NIL: NIL

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: INclusion is Not applicable for this study

Exclusion criteria

Exclusion criteria: Exclusion is not applicable for this study

Design outcomes

Primary

MeasureTime frame
1. Quantification of left over parenteral drug from the oncology ward over a period of six monthsTimepoint: six months—

Secondary

MeasureTime frame
1. Estimation of drug wastage and economic loss anti-cancer drugs in an oncology ward over a period of six months 2. Simulation of ideal dosage strength and vial volume for individual drugs for an average patient in our population that minimize drug wastage Timepoint: six months—

Countries

India

Contacts

Public ContactGopisankar MG

NEIGRIHMS

juliewahlang@gmail.com08794732665

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026